Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jun 1;127(11):1939.
doi: 10.1002/cncr.33431. Epub 2021 Mar 15.

Reply to COVID-19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors

Affiliations
Comment

Reply to COVID-19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors

Chiara Cattaneo et al. Cancer. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors made no disclosures.

Comment on

References

    1. Cattaneo C, Daffini R, Pagani C, et al. Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID‐19. Cancer. 2020;126:5069‐5076.doi:10.1089/jwh.2020.8590 - DOI - PubMed
    1. Breccia M, Abruzzese E, Bocchia M, et al. Chronic myeloid leukemia management at the time of the COVID‐19 pandemic in Italy. A campus CML survey. Leukemia. 2020;34:2260‐2261.doi:10.1038/s41375-020-0904-z - DOI - PMC - PubMed
    1. Li W, Wang D, Guo J, et al. COVID‐19 in persons with chronic myeloid leukaemia. Leukemia. 2020;34:1799‐1804.doi:10.1038/s41375-020-0853-6 - DOI - PMC - PubMed
    1. Rizzo AN, Aman J, van Nieuw Amerongen GP, Dudek SM. Targeting Abl kinases to regulate vascular leak during sepsis and ARDS. Arterioscler Thromb Vasc Biol. 2015;35:1071‐1079.doi:10.1161/ATVBAHA.115.305085 - DOI - PMC - PubMed
    1. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID‐19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054‐1062.doi:10.1016/S0140-6736(20)30566-3 - DOI - PMC - PubMed

Substances